Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01540136
What this trial is testing

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 402
Testing effectiveness (Phase 2)Looking for participantsNCT06912711
What this trial is testing

TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 70
Early research (Phase 1)Study completedNCT04636632
What this trial is testing

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 100
Not applicableLooking for participantsNCT07412314
What this trial is testing

Proton Therapy for Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Guangzhou Concord Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT02608073
What this trial is testing

Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Hoffmann-La Roche 45
Testing effectiveness (Phase 2)Study completedNCT04350190
What this trial is testing

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 25
Not applicableLooking for participantsNCT05126160
What this trial is testing

Immune Score Based Radiomics in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 494
Testing effectiveness (Phase 2)Ended earlyNCT01525927
What this trial is testing

Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity

Who this might be right for
Oropharyngeal Neoplasms
Northwell Health 2
Early research (Phase 1)Active Not RecruitingNCT02065362
What this trial is testing

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

Who this might be right for
EBV-positive Nasopharyngeal Carcinoma
Baylor College of Medicine 14
Not applicableStudy completedNCT07139054
What this trial is testing

68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Cancer
The First Affiliated Hospital of Xiamen University 31
Testing effectiveness (Phase 2)UnknownNCT05981157
What this trial is testing

Anrotinib and Tirelizumab in First-line Treatment of RM-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China 27
Not applicableUnknownNCT03048305
What this trial is testing

Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Study completedNCT00436800
What this trial is testing

Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sanofi 41
Early research (Phase 1)Ended earlyNCT00080028
What this trial is testing

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharynx CancerLarynx Cancer+1 more
Pharmacyclics LLC. 18
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Not applicableLooking for participantsNCT06870435
What this trial is testing

Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas

Who this might be right for
Nasopharyngeal Carcinoma (NPC)ScreeningEpstein Barr Virus
Ming-Yuan Chen 68,649
Not applicableStudy completedNCT00765791
What this trial is testing

2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Alberta 40
Testing effectiveness (Phase 2)UnknownNCT03778008
What this trial is testing

Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis

Who this might be right for
Stomatitis
Second Affiliated Hospital of Nanchang University 90
Early research (Phase 1)Looking for participantsNCT06747390
What this trial is testing

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCCA)Oropharyngeal CancerHuman Papilloma Virus+1 more
Ryan Carey 30
Not applicableUnknownNCT02481089
What this trial is testing

Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaSingle Nucleotide PolymorphismsRadiosensitivity
Hunan Province Tumor Hospital 600
Next Page